Please login to the form below

Not currently logged in
Email:
Password:

epilepsy

This page shows the latest epilepsy news and features for those working in and with pharma, biotech and healthcare.

Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’

Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’

This was driven by competition for epilepsy drug Lyrica (pregabalin) in the US, as well as lower revenue for key drugs in China due to the impact from the country’s

Latest news

  • Sanofi faces manslaughter allegations in France over Depakine deaths Sanofi faces manslaughter allegations in France over Depakine deaths

    Sanofi is being investigated for manslaughter charges in France relating to side-effects caused by the company’s anti-epilepsy drug Depakine (valproate). ... This means that women treated with Depakine for epilepsy were up to four times likelier to

  • US piles pressure on Mallinckrodt over alleged Acthar fraud US piles pressure on Mallinckrodt over alleged Acthar fraud

    thanks to new indications, including a 2010 approval – under a New Drug Application – for the treatment of infantile spasms, an extremely rare, potentially fatal form of epilepsy.

  • Sanofi indicted in France over epilepsy drug birth defects Sanofi indicted in France over epilepsy drug birth defects

    Sanofi has revealed that it has been indicted in France in connection with an investigation over birth defects linked to one of its epilepsy drugs. ... Despite its maturity, the drug has been one of Sanofi’s reliable mid-size products, bringing in

  • Congenica launches new application Congenica Neuro Congenica launches new application Congenica Neuro

    Provides faster analysis of epilepsy and neurodevelopmental disorders. Digital health company Congenica has launched a new application on its clinical decision support programme named Congenica Neuro. . ... Around 300 million people around the world

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug. The UK’s competition regulator is pushing to reinstate a £90m fine for Pfizer and Flynn Pharma – quashed last year – over ... to treat epilepsy for decades, which at the time was

More from news
Approximately 32 fully matching, plus 182 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics